Recipharm has unveiled plans to invest €18 million to expand its blow fill seal (BFS) capacity at its site in Kaysersberg, France.

The investment will see the introduction of a new blow fill seal high speed filling and packaging line, bringing the total number of lines from seven to eight to meet growing demand for the service.

Preparations will also be made to add a further three filling lines over the coming years, more than doubling the size of the CDMO’s operations from 2,000 square meters to 4,150 square meters and increasing its blow fill seal capacity by 50 percent. The first of the four planned filling lines will allow Recipharm to support more drug developers with the aseptic processing of sterile liquids such as eye care and ear drops into plastic containers.

“We are experiencing increased demand for our blow fill seal services from markets including the U.S., Turkey, Australia and Canada and the new filling line will help us to meet this growing need,” said Yves Buelens, general manager at Recipharm’s Kaysersberg site. “The increased capacity will position us well for future growth and allow us to take on new projects from new customers more swiftly. With the site’s big pharma heritage, we are ideally placed to meet the highest quality and regulatory requirements and are committed to investing in the facility to ensure we can continue to deliver the best possible service.”

Visit Recipharm at Table 37